SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

24 May 2022 Evaluate
The revenue for the March 2022 quarter is pegged at Rs. 1065.53 millions, about 13.33% up against Rs. 940.17 millions recorded during the year-ago period.Net Profit recorded in the quarter ended March 2022 rise to 43.77% to Rs. 147.06  millions  compared to R. 102.29 millions in corresponding previous quarter.Operating profit surged to 215.13 millions from the corresponding previous quarter of 150.69 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1065.53 940.17 13.33 4058.42 3328.44 21.93 4058.42 3328.44 21.93
Other Income 51.60 26.81 92.47 153.83 113.20 35.89 153.83 113.20 35.89
PBIDT 215.13 150.69 42.76 948.56 860.73 10.20 948.56 860.73 10.20
Interest 3.01 3.67 -17.98 4.85 5.00 -3.00 4.85 5.00 -3.00
PBDT 212.12 147.02 44.28 943.71 855.73 10.28 943.71 855.73 10.28
Depreciation 11.93 9.90 20.51 37.95 36.70 3.41 37.95 36.70 3.41
PBT 200.19 137.12 46.00 905.76 819.03 10.59 905.76 819.03 10.59
TAX 53.13 34.83 52.54 233.88 207.14 12.91 233.88 207.14 12.91
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 147.06 102.29 43.77 671.88 611.89 9.80 671.88 611.89 9.80
Equity 29.23 29.23 0.00 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 20.19 16.03 25.97 23.37 25.86 -9.62 23.37 25.86 -9.62

Amrutanjan Healthcar Share Price

546.50 7.85 (1.46%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×